/cloudfront-us-east-2.images.arcpublishing.com/reuters/3JANUNFCQBMEXCYCF54KK2G24I.jpg)
A street sign for Wall Street hangs in front of the New York Stock Exchange May 8, 2013. REUTERS/Lucas Jackson/File Photo Acquire Licensing Rights NEW YORK, Dec 5 (Reuters) – Global bank executives said that dealmaking conditions have begun to improve, with some predicting a better outlook for strategic mergers and acquisitions at an industry … Read more
/cloudfront-us-east-2.images.arcpublishing.com/reuters/6FNAFVDOJNM65EKIL5LZ6FSYPA.jpg)
Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., October 27, 2023. REUTERS/Brendan McDermid Acquire Licensing Rights Tech sector jumps, helped by Microsoft, Nvidia Investors looking ahead to CPI next week Illumina falls on annual profit forecast cut Nov 10 (Reuters) – Wall Street’s main indexes ended … Read more
/cloudfront-us-east-2.images.arcpublishing.com/reuters/IS7A4TKOVJKXJI5NRWNGEAFI3M.jpg)
Signage for Cigna is pictured at a health facility in Queens, New York City, U.S., November 30, 2021. REUTERS/Andrew Kelly/File Photo Acquire Licensing Rights NEW YORK, Nov 6 (Reuters) – U.S. health insurer Cigna Group (CI.N) is exploring the sale of its Medicare Advantage business, which manages government health insurance for people aged 65 and … Read more
Oct 18 (Reuters) – Health insurer Elevance Health (ELV.N) raised its annual adjusted profit outlook and beat Wall Street estimates for third-quarter profit on Wednesday, on the back of lower-than-expected medical costs, sending shares over 2% higher. Elevance, however, took a nearly $700 million charge due to job cuts and write-offs from some technology assets … Read more
/cloudfront-us-east-2.images.arcpublishing.com/reuters/CS2QMKRGT5MUNC3ACGTLMALMFY.jpg)
[1/2]A Kaiser Permanente health care center is pictured in Anaheim, California, U.S., October 3, 2023 as more than 75,000 Kaiser Permanente healthcare workers could go on strike from Oct. 4 to Oct. 7 across the United States. REUTERS/Mike Blake Acquire Licensing Rights WASHINGTON, Oct 3 (Reuters) – Kaiser Permanente appeared headed for a labor clash … Read more
/cloudfront-us-east-2.images.arcpublishing.com/reuters/VUGWIKRVFJJ3FBIGWKEHQ6FHUY.jpg)
[1/9]A guest attends a presentation of the updated virtual reality headset during the Meta Connect event at the company’s headquarters in Menlo Park, California, U.S., September 27, 2023. REUTERS/Carlos Barria Acquire Licensing Rights MENLO PARK, California, Sept 27 (Reuters) – Meta Platforms (META.O) Chief Executive Mark Zuckerberg on Wednesday rolled out new AI products for … Read more
/cloudfront-us-east-2.images.arcpublishing.com/reuters/3FFQ6QOVPVJJFMCJGBYD3CTBN4.jpg)
The Wall Street entrance to the New York Stock Exchange (NYSE) is seen in New York City, U.S., November 15, 2022. REUTERS/Brendan McDermid/File Photo Acquire Licensing Rights NEW YORK, Aug 25 (Reuters) – U.S. stock investors are bracing for a potentially volatile September as the market faces key economic data reports, a Federal Reserve meeting … Read more
/cloudfront-us-east-2.images.arcpublishing.com/reuters/T6BNM4HBWBPB3MOMJ7ZD3LB7BY.jpg)
The offices of gene sequencing company Illumina Inc are shown in San Diego, California January 11, 2016. REUTERS/Mike Blake/File Photo Aug 9 (Reuters) – Illumina Inc (ILMN.O) cut annual profit forecast, in a sign that a funding crunch among its biotech and pharmaceutical clients is expected to weigh on sales for its genetic testing tools … Read more
/cloudfront-us-east-2.images.arcpublishing.com/reuters/7WM2Y5LJJRPNBJPVA46YRDXNVA.jpg)
Traders work on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., July 20, 2023. REUTERS/Brendan McDermid/File Photo Fitch cuts US credit rating to AA+ Wells Fargo slides on plan to help refill FDIC coffers U.S. private payrolls beat expectations in July, ADP says Indexes down: Dow 0.98%, S&P 1.38%, … Read more
/cloudfront-us-east-2.images.arcpublishing.com/reuters/K6ZXQDLC3FJSJI4AIU3XXNYONM.jpg)
CHICAGO, July 31 (Reuters) – Quest Diagnostics (DGX.N) on Monday launched the first direct-to-consumer blood test to detect abnormal levels of beta amyloid, a key Alzheimer’s disease protein that can appear years before dementia symptoms arise. The $399 test, called AD-Detect, uses the same technology as a blood test the company began selling for use … Read more